Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.64 USD | +1.14% | +3.45% | +4.65% |
05-08 | Syndax Pharmaceuticals Q1 Net Loss Widens | MT |
05-08 | Transcript : Syndax Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.65% | 1.9B | |
+23.99% | 46.71B | |
+48.83% | 41.8B | |
-1.05% | 41.52B | |
-3.42% | 29.55B | |
+10.63% | 25.78B | |
-20.93% | 19.26B | |
-0.44% | 12.14B | |
-0.58% | 12.08B | |
+26.06% | 11.98B |
- Stock Market
- Equities
- SNDX Stock
- News Syndax Pharmaceuticals, Inc.
- JPMorgan Raises Price Target on Syndax Pharmaceuticals to $34 From $31, Maintains Overweight Rating